Autopsy report · NCT00087256

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

“For scientific, logistic, and administrative reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 18 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

NSABP Foundation Inc

Sponsor type

University, hospital or other

Conditions

Colorectal Cancer

Interventions

Celecoxib; placebo

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• Comparing the Effect of TAP-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery
  “Because of logistic and practical reasons.” (78% match in meaning)
• Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
  “For business reasons.” (65% match in meaning)
• Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
  “Administrative reasons.” (61% match in meaning)
• Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
  “for strategic reasons” (60% match in meaning)
• RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
  “Business reasons.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.